Kilpatrick S E, Teot L A, Geisinger K R, Martin P L, Shumate D K, Zbieranski N, Russell G B, Fletcher C D
Department of Pathology, North Carolina Baptist Hospital, Bowman Gray School of Medicine, Winston-Salem, North Carolina.
Cancer. 1994 Dec 15;74(12):3227-33. doi: 10.1002/1097-0142(19941215)74:12<3227::aid-cncr2820741223>3.0.co;2-x.
Although DNA ploidy correlates with prognosis in certain childhood cancers, e.g., neuroblastoma, its significance in rhabdomyosarcoma (RMS) is unclear and controversial.
Ploidy by flow cytometry (FCM) and image analysis (IA) in 26 of 27 children with RMS (17 embryonal, 3 mixed embryonal/alveolar, 5 alveolar, 1 anaplastic, 1 ectomesenchymoma) and 4 adults with pleomorphic RMS were evaluated. Statistical comparisons were analyzed between DNA content and gender, age, localization, Intergroup Rhabdomyosarcoma Study (IRS) group, and histopathologic subtype. Survival analyses were performed by the Kaplan-Meier test using the approximate chi-square statistic for the log rank test.
The concordance rate between FCM and IA was 26 of 30 (87%); FCM was not performed in one tumor. Image analysis was more sensitive than FCM in detecting aneuploidy. Furthermore, DNA content was associated significantly with histologic subtype (P = 0.031); embryonal histology commonly was hyperdiploid (mean, 1.44; median, 1.27), whereas alveolar histology usually was near-tetraploid (mean, 1.83; median, 1.95). All four adult patients with pleomorphic RMS were aneuploid, with one showing multiple DNA peaks. No correlation between DNA content and survival was observed in the children with RMS. However, IRS group (P = 0.011) and patient age (P = 0.036) were independent prognostic indicators significantly related to survival. All adult patients died of their disease.
Although ploidy correlates with histologic subtype, DNA content is not significantly predictive of prognosis in patients with RMS. Age at diagnosis and IRS group are independent predictors of clinical outcome in children with RMS.
尽管DNA倍体与某些儿童癌症(如神经母细胞瘤)的预后相关,但其在横纹肌肉瘤(RMS)中的意义尚不清楚且存在争议。
对27例RMS患儿中的26例(17例胚胎型、3例胚胎型/肺泡型混合、5例肺泡型、1例间变性、1例外胚层间叶瘤)以及4例多形性RMS成人患者进行流式细胞术(FCM)和图像分析(IA)检测倍体。分析DNA含量与性别、年龄、部位、横纹肌肉瘤研究组(IRS)分组以及组织病理学亚型之间的统计学差异。采用Kaplan-Meier检验进行生存分析,并使用对数秩检验的近似卡方统计量。
FCM与IA的一致性率为30例中的26例(87%);1例肿瘤未进行FCM检测。图像分析在检测非整倍体方面比FCM更敏感。此外,DNA含量与组织学亚型显著相关(P = 0.031);胚胎型组织学通常为超二倍体(均值1.44;中位数1.27),而肺泡型组织学通常接近四倍体(均值1.83;中位数1.95)。4例多形性RMS成人患者均为非整倍体,其中1例显示多个DNA峰。RMS患儿中未观察到DNA含量与生存之间的相关性。然而,IRS分组(P = 0.011)和患者年龄(P = 0.036)是与生存显著相关的独立预后指标。所有成人患者均死于疾病。
尽管倍体与组织学亚型相关,但DNA含量对RMS患者的预后并无显著预测价值。诊断时的年龄和IRS分组是RMS患儿临床结局的独立预测因素。